These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19995078)

  • 1. NMR structure in a membrane environment reveals putative amyloidogenic regions of the SEVI precursor peptide PAP(248-286).
    Nanga RP; Brender JR; Vivekanandan S; Popovych N; Ramamoorthy A
    J Am Chem Soc; 2009 Dec; 131(49):17972-9. PubMed ID: 19995078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency.
    Brender JR; Nanga RP; Popovych N; Soong R; Macdonald PM; Ramamoorthy A
    Biochim Biophys Acta; 2011 Apr; 1808(4):1161-9. PubMed ID: 21262195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semen-derived amyloidogenic peptides-Key players of HIV infection.
    Lee YH; Ramamoorthy A
    Protein Sci; 2018 Jul; 27(7):1151-1165. PubMed ID: 29493036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.
    Elias AK; Scanlon D; Musgrave IF; Carver JA
    Biochim Biophys Acta; 2014 Sep; 1844(9):1591-8. PubMed ID: 24948476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion.
    Brender JR; Hartman K; Gottler LM; Cavitt ME; Youngstrom DW; Ramamoorthy A
    Biophys J; 2009 Nov; 97(9):2474-83. PubMed ID: 19883590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide.
    Olsen JS; DiMaio JT; Doran TM; Brown C; Nilsson BL; Dewhurst S
    J Biol Chem; 2012 Apr; 287(15):11842-9. PubMed ID: 22354963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.
    Ren R; Yin S; Lai B; Ma L; Wen J; Zhang X; Lai F; Liu S; Li L
    Retrovirology; 2018 Jul; 15(1):49. PubMed ID: 30012153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen.
    Easterhoff D; Ontiveros F; Brooks LR; Kim Y; Ross B; Silva JN; Olsen JS; Feng C; Hardy DJ; Dunman PM; Dewhurst S
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2443-50. PubMed ID: 23507280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.
    Allen SA; Carias AM; Anderson MR; Okocha EA; Benning L; McRaven MD; Kelley ZL; Lurain J; Veazey RS; Hope TJ
    J Virol; 2015 May; 89(10):5569-80. PubMed ID: 25740984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Seminal Amyloids as Targets for Development of Synthetic Inhibitors of HIV Transmission.
    Sheik DA; Dewhurst S; Yang J
    Acc Chem Res; 2017 Sep; 50(9):2159-2166. PubMed ID: 28809479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual concentration-dependent effect of ascorbic acid on PAP(248-286) amyloid formation and SEVI-mediated HIV infection.
    Mohapatra S; Viswanathan GKK; Wettstein L; Arad E; Paul A; Kumar V; Jelinek R; Münch J; Segal D
    RSC Chem Biol; 2021 Oct; 2(5):1534-1545. PubMed ID: 34704058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286).
    Popovych N; Brender JR; Soong R; Vivekanandan S; Hartman K; Basrur V; Macdonald PM; Ramamoorthy A
    J Phys Chem B; 2012 Mar; 116(11):3650-8. PubMed ID: 22360607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.
    Roan NR; Münch J; Arhel N; Mothes W; Neidleman J; Kobayashi A; Smith-McCune K; Kirchhoff F; Greene WC
    J Virol; 2009 Jan; 83(1):73-80. PubMed ID: 18945786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.
    Xun T; Li W; Chen J; Yu F; Xu W; Wang Q; Yu R; Li X; Zhou X; Lu L; Jiang S; Li L; Tan S; Liu S
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5123-34. PubMed ID: 26055369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAP(248-286) Conformational Changes during the Lag Phase of Amyloid Fibril Formation.
    Kusova AM; Yulmetov AR; Blokhin DS
    Biochemistry; 2023 Jun; 62(12):1906-1915. PubMed ID: 37246528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of semen-derived enhancer of virus infection (SEVI) fibrillogenesis by zinc and copper.
    Sheftic SR; Snell JM; Jha S; Alexandrescu AT
    Eur Biophys J; 2012 Sep; 41(9):695-704. PubMed ID: 22907203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of HIV-1 infectivity by simple, self-assembling modular peptides.
    Easterhoff D; DiMaio JT; Doran TM; Dewhurst S; Nilsson BL
    Biophys J; 2011 Mar; 100(5):1325-34. PubMed ID: 21354406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.
    Castellano LM; Bart SM; Holmes VM; Weissman D; Shorter J
    Chem Biol; 2015 Aug; 22(8):1074-86. PubMed ID: 26256479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection.
    Arnold F; Schnell J; Zirafi O; Stürzel C; Meier C; Weil T; Ständker L; Forssmann WG; Roan NR; Greene WC; Kirchhoff F; Münch J
    J Virol; 2012 Jan; 86(2):1244-9. PubMed ID: 22090109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
    Kim KA; Yolamanova M; Zirafi O; Roan NR; Staendker L; Forssmann WG; Burgener A; Dejucq-Rainsford N; Hahn BH; Shaw GM; Greene WC; Kirchhoff F; Münch J
    Retrovirology; 2010 Jun; 7():55. PubMed ID: 20573198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.